What ARE the side effects of LYNAVOY?
Adverse reactions occurring in ≥5% of adult patients with PBC treated with LYNAVOY in GLISTEN study (24 weeks)1*
| Adverse Reaction | LYNAVOY (n=119) n (%) | Placebo (n=118†) n (%) |
|---|---|---|
| Diarrhea‡ | 74 (62) | 21 (18) |
| Abdominal pain§ | 31 (26) | 12 (10) |
| Nausea | 12 (10) | 11 (9) |
| Increased ALT | 11 (9) | 4 (3) |
| Hemorrhage|| | 11 (9) | 3 (3) |
| Increased AST | 10 (8) | 1 (<1) |
| Headache | 10 (8) | 4 (3) |
| Dyspepsia | 9 (8) | 1 (<1) |
| Gastroesophageal reflux disease | 8 (7) | 5 (4) |
| Abdominal distension | 8 (7) | 6 (5) |
| Dizziness | 7 (6) | 4 (3) |
| Arthralgia | 7 (6) | 6 (5) |
Drug discontinuation due to diarrhea occurred in 4% of LYNAVOY-treated patients and <1% of placebo-treated patients1
Drug discontinuation due to adverse reactions occurred in 14% of LYNAVOY-treated patients and 5% of placebo-treated patients1
* Adverse reactions were only included in table if they occurred more frequently in patients treated with LYNAVOY compared to placebo-treated patients.1
† One patient randomly assigned to the placebo group withdrew before receiving treatment.7
‡ Diarrhea includes diarrhea and frequent bowel movements.1
§ Abdominal pain includes abdominal pain, abdominal pain upper, abdominal pain lower, abdominal discomfort.1
|| Hemorrhage includes contusion, ecchymosis, epistaxis, gastric hemorrhage, hematochezia, hemorrhagic disorder, intermenstrual bleeding, melena, petechiae, skin hemorrhage, vaginal hemorrhage, hematocrit decreased, and diarrhea hemorrhagic.1
ALT=alanine aminotransferase; AST=aspartate aminotransferase.